Browsing: LDL-C

In a significant development, Novartis has launched a cutting-edge therapy designed to lower bad cholesterol levels, providing hope for patients at high risk of cardiovascular issues. This innovative treatment has the potential to dramatically improve the lives of those dealing with high cholesterol, a key risk factor for heart disease and stroke.

Recent findings question the role of Niacin, also known as nicotinic acid, in cardiovascular health, revealing its dangerous impact on vascular inflammation. Careful approaches are advised for cardiovascular management.